Skip to content

Clinical trials

Recruiting Lymphoma, B-Cell, Marginal Zone trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Recruiting Country / region: Germany Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20211
20221
20233
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
iOMEDICO AG2
BeOne Medicines1
Eli Lilly and Company1
Regeneron Pharmaceuticals1
The Lymphoma Academic Research Organisation1
University Hospital Muenster1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular6
Lymphoma, Non-Hodgkin4
Waldenstrom Macroglobulinemia4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Mantle-Cell3
Lymphoma, B-Cell2
Immune System Diseases1
Immunoproliferative Disorders1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.